Immune activation by combination human lymphokine-activated killer and dendritic cell therapy

Reovirus Activates Human Dendritic Cells to Promote Innate Antitumor Immunity

(2014) Fiona Errington et al.   JOURNAL OF IMMUNOLOGY

Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response

(2010) A. Reschner et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30

(2009) Mirna Balsamo et al.   EXPERIMENTAL HEMATOLOGY

DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases

(2009) C. J. Chan et al.   JOURNAL OF IMMUNOLOGY

Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity

(2008) R. J. Prestwich et al.   CLINICAL CANCER RESEARCH

Natural killer cell immunotherapy for cancer: a new hope

(2008) S. Srivastava et al.   CYTOTHERAPY

Melanoma and Lymphoma Rejection Associated With Eosinophil Infiltration Upon Intratumoral Injection of Dendritic and NK/LAK Cells

(2008) Annalisa Capobianco et al.   JOURNAL OF IMMUNOTHERAPY

Clinical Grade OK432-activated Dendritic Cells

(2008) Emma West et al.   JOURNAL OF IMMUNOTHERAPY